A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Clinical trial NCT05576974 · RECRUITING

Trial details

NCT number: NCT05576974
Sponsor: University of Texas Southwestern Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Unknown Primary Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2024-04-17
Primary completion: 2027-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.